Health and Shopping Blog

On its site, the American Massage Therapy Association reports that more people are turning to massage therapy for medical purposes rather than for relaxation. But the baby boomers are more committed to massage than the young with an average seven session in the last year. This reflects a general trend. Its most recent survey reports 24% of adult Americans received one massage during 2007 (43% adult women and 25% adult men had a massage during the last five years). More people now use massage as a component in their wellness programs or pain management strategies. This does not deny the effectiveness of tramadol or other painkillers.

This represents a groundswell in favor of physical therapy with 20% reporting that their doctors and healthcare providers had strongly encouraged massage. This is echoed in figures from the registered AMTA members. Almost three-fifths reported an increase in referrals from healthcare professionals. Curiously, 70% also make the service open to their own staff. More than half those surveyed wanted their medical insurers to include massage therapy. If it was better integrated into healthcare, the AMTA believes there would be a significant improvement in quality of treatment for chronic pain and stress. Massage with a judicious use of tramadol is good for you.

Ask a doctor how to cope with moderate to severe pain and the most common answer is to use Ultram. It’s true that the profession of doctor is under pressure. Not enough doctors are prepared to work in general practice. But prescribing pills is a lazy answer. The key issue is that, rightly or wrongly, painkillers have a bad press. Open a newspaper and you’ll routinely see stories of people arrested for dealing in narcotic painkillers, or hooked on them and going into rehab. People need reassurance that a drug like Ultram is safe. Sometimes, it’s at the light end with massage. Other times, it’s at the heavy end with manipulation.

Your aim is simple. Pain often arises because joints stiffen and people lose muscle tone through inactivity. So many people need to be reintroduced to the idea of mobility. In this, the social interaction between the patient and the therapist is crucial. If trust is established, people work their way through the fear of movement to find they can move without feeling pain or with less pain than they expected. This doesn’t mean people should avoid Ultram. It simply means they should take Ultram only for a limited time and work more at getting better naturally.

Because tooth whitening can be accomplished in number of ways, acquiring a whiter, brighter smile is not that difficult. It’s sad but true; the models in the journals always seem to have whiter teeth than you do, no matter how conscientious you are about caring for your teeth.

Dental Office Treatments: Advanced bleaching treatments are available from your dentist; these last a long time and are quite effective. The treatments range in price from $300 to $500 so are they can be quite expensive. This is the most effective treatment method, if you can afford it.

Brush-on Methods: If you are hoping not to spend too much money, then brush on treatments might be the best method for you. A two week-kit is quite affordable, in some cases only costing about $3. The applications can be quite difficult and messy. You can also wake up with terrible morning breath after using these products.

Whitening Mouthwashes and Toothpastes: Although they do not work as well as professional dental whitening treatments, mouthwashes and toothpastes that claim to help whiten teeth can be effective. The results may not be immediate, though. These work best on light to medium stains. They work very well as a preventative and maintenance measure and are more affordable than many other methods.

Whitening Strips: Depending on the quality, whitening strips can cost as much as $40+, and are readily available at all drug and grocery stores. The strips that cost the least work well only when used on a regular basis. The more expensive strips will provide results that almost match the effectiveness of teeth whitening treatments provided in a dental office. You don’t want to have stripes on your teeth due to uneven whitening, so care must be taken during application. Increased tooth sensitivity can occur as a result of using whitening strips.

There are a long list of teeth whitening methods available to help whiten your teeth. No matter which method you choose, remember that regular visits to your dentist and a change in diet can help to maintain a whiter, brighter smile for many years to come.

Article From www.10minteethwhitening.com

Sometimes, a clown is more that just a comediant, he hits the right note of humor and intelligence to pass through the television screen and feel like a real human being. So often actors and comedians are trying too hard. There’s an archness about their performance. Bernie Mac was a rare talent. This is an autoimmune disease that, somewhat unfairly, operates along racial lines. Black Americans are sixteen times more likely to die than white yankees. There is no cure for this disease. And this is very mournful. It can affect any part of the body where groups of cells clump together. Where these so-called granulomas occur, the body is damaged. The standard treatment is Prednisone. Bernie Mac had been in remission for some three years before his death. Although there are some side effects if you take a steroid like Prednisone over longer periods of time, e.g. an increase in body weight, fluid retention, etc. these are prices worth paying for those with this disease. Often affecting the lungs and leaving you breathless, people are left without energy. That Bernie Mac kept going and entertained so many for so long is a testament to the kind of man he was and the therapeutic quality of Prednisone.

It is always very interesting to watch how the media pick up on a story from the world of researches in medicine. No matter how well balanced and scientifically neutral the source material may be, it seems that news must always be more sensational. Only the bad news can make marketers smile. Take a headline, “Toothpaste gives you cancer!” Don’t be afraid. I just made that up, but you get the idea. So, as responsible journalists, how should we approach an article in the January edition of Diabetes Research & Clinical Practice? I suppose. Actually approaching it in the first place is difficult because this is hardly a hot-from-the-presses must-read magazine. You actually have to search for research with a magnifying glass. The majority were taking either or both a SSRI like Zoloft or a TCA like Aventyl or Elavil. So let me begin my article with two relevant findings: if you live in Saskatchewan and you are depressed, you are 30% more likely to develop type 2 diabetes than someone who is not depressed; and if you take two medications at the same time, this doubles the likelihood that you will develop diabetes. I can already feel the headlines bubbling up: Living is Saskatchewan is dangerous to your health! Zoloft ate my hamster and got diabetes. The TCAs were first used in the 1950s but, as the newer medications including the SSRIs have come on to the markets, the TCAs have been increasingly phased out because they are considered more likely to cause side effects. Thus, in the period covered by the research, it would not be surprising that patients should be taking both. Either they would be phasing out, say, Moxdil in favor of the newer Zoloft (introduced in 1991) or they were adopting a belt-and-braces approach and combining the old with the new, hoping for the best result. Today, it should be quite unusual to find a significant number of people taking Zoloft and one of the TCAs. But, if you are one of these people, you should stop taking the TCA right now. So let us be absolutely clear on the message here. There is no link in this research between Zoloft and diabetes. Indeed, in the literature, there is a considerable body of evidence to show that the link is more certainly between a depressive illness and diabetes, cardiovascular diseases, etc. The reason is scientific confirmation of a common sense or intuitive truth. So, there is no need to change from Zoloft on the basis of this research, but you still have to watch out for Emperor Zoloft and his hungry-for-hamsters evil empire.

The problem is judging how much to explain. Sometimes, we explain everything as in the series of books for men who don’t understand the theme of articles much. That’s everything you didn’t know about most things in big yellow packages. So here I am writing about the best painkiller, ultram, and then I realized I might be assuming that everyone knows all there is to know about severe pain - other than it hurts, of course. To fill in the gaps, I therefore offer the following quick guide. Pain is acute when it’s severe but it’s only going to last for a short period of time. A good example would be the pain you feel after you’ve been cut open for surgery. Apart from the scapel-wielding surgeon, the reason for this kind of pain is to act as a warning not to move around too much. The body is telling you that more movement is going to cause more tissue damage. So, ultram works well to give you immediate relief both while your body heals and as you begin to exercise again to rebuild muscle tone. If your pain don’t go away, it is termed chronic and becomes a disease process in its own right. Many factors can contribute to converting short-term into long-term pain. It may be a function of the initial injury or disease, whether there is nerve damage, the onset of depression or age. The latest studies of neuroplasticity show that severe acute pain can become chronic because the process to limit the transmission of pain messages breaks down. The nervous system slowly becomes more sensitive and reacts more strongly to pain signals. If the pain is localized at the site of an injury or some other physical problem such as arthritis, and you feel it as sharp, throbbing or aching, this is described as nociceptive. Treatment with non-steroidal anti-inflammatory drugs (NSAIDs) and stronger painkillers such as ultram are recommended. So this post was mild and acute and, because it’s a known cause, the resulting pain was nociceptive. Nerves learn or remember pain. New habits form. Again ultram can suppress pain signals but, this treatment should be accompanied by cognitive behavioral therapy to learn how to cope with pain. When you experience symptoms of shooting, electric, tingling or burning but there are no obvious causes, this is described as neuropathic pain. As with chronic pain, treatment with ultram slows down the pain and gives you a breathing space during which physiotherapy, relaxation training and other pain management techniques are applied.

Perhaps I am growing more angry, but every time I see a new piece of research only lasting one or two years, I wonder why it stopped just now. I suppose it is always a balancing act. If you have a specific hypothesis, evidence for or against should be apparent fairly quickly. This is very convenient for the manufacturers which might have to pull a medication from the market if adverse evidence emerged. This leaves a moral question: who puts a value on one or two lives lost when millions may be benefiting from the medication? Thus, if a company believes it has the new blockbuster drug, administering it to some brave volunteers should produce good results or lose credibility in months. Anyway, the longer a trial goes on, the more difficult it gets to distinguish between potential causes and their effects. So when one or two participants develop a heart condition or get depressed, is this a side effect of the medication under test or a coincidence? In many cases, the answer only emerges over time. But no-one is systematically collecting longitudinal data.

The study shows that most of the group found the insomnia growing steadily more pronounced as the years passed. You might wonder why they were not all buy ambien or an equivalent. The answer, of course, is that they were and to excellent short-term effect. But these powerful medications are only used in moderation and not over long periods of time. Further, the medications are not cures in the literal sense of the word. They merely give relief during which time those who suffer may attempt to relearn the art of sleep. The study concludes that insomnia is persistent and increases the risk of depressive conditions.

• once formed, insomnia can be hard to break - only cognitive behavioural therapy or counselling can modify habits over the long term;
• the disruption to sleep patterns is more closely linked to depression - as the medical profession is wont to say, they are comorbid conditions.

The final thought has to be that if you are unlucky enough to suffer from insomnia, take ambien as directed by your doctor. The combination is the best chance of avoiding long-term problems.

Foreword

At the meeting of the American College of Cardiology held in Chicago this March, Merck&Co released some clinical data from the Phase III trials for their proposed competitor to acomplia (rimonabant). This new medication, still going by its generic name of taranabant, targets the same cannabinoid system as acomplia. It is therefore interesting to compare results since, if it gains regulatory approval, it will be a direct competitor to acomplia.

In conjunction with a diet and exercise program, 28% of those taking a 2mg dose of taranabant lost more than 10% of their body weight, while 57% lost 5% of their body weight. Almost 8% of those on placebo also lost 10% of their body weight through diet and exercise alone. In terms of averages, participants taking a 2mg dose of taranabant lost 14.5 pounds compared to 5.7 pounds on placebo.

In 2004, Acomplia’s results were that 32% on Acomplia lost more than 10% of their body weight while 62.5% lost more than 5% of their body weight. But these results were obtained at the higher dosage of 20mg as opposed to 2mg taranabant. The reason for the difference in the dosage levels is that acomplia is a CB1 receptor antagonist that blocks endogenous cannabinoid binding to neuronal CB1 receptors, while taranabant acts as a selective cannabinoid-1 receptor inverse agonist, binding to CB1 receptors. I am glad we have got that clear.

Because both medications work in a similar way, it always seemed likely that they would have similar problems with central nervous system side effects. Given that acomplia was given a rough ride by the FDA, it would seem unlikely that taranabant will fare any better on the information so far made public. Although both seem to improve the levels of high-density cholesterol and to bring down the level of triglycerides which will help to reduce the risk of heart disease, the fact that both have been associated with feelings of depression and, in some cases, suicide will probably mean that neither will be approved in the US in the near future. Even if the current trials for acomplia produce results with few or no central nervous system side effects, the results of taranabant may still drag acomplia down. If taranabant is also producing unacceptable levels of psychological disturbance at 4mg, acomplia does not look so good at higher dosages.

Nevertheless, this must be placed in a proper context. Acomplia has, of course, been available on prescription in Europe for two years and there is no emerging evidence of problems sufficiently serious to justify withdrawing approval. Indeed, it has just been given a further level of approval in the UK. If acomplia continues to accumulate a positive safety record, this may offset any prejudicial implications in the US from the taranabant trials. What should be relatively uncontroversial is that the use of the cannabinoid system for the treatment of obesity should remain firmly on the research agenda. Acomplia continues to offer an effective supplement to diet and exercise regimes. As its effects are better understood, the reported side effects may be better controlled.

Merck & Co also tested higher doses of 4mg and 6mg but admitted problems with psychiatric side effects. It confirmed that taranabant would probably only be brought to the market at the lowest 2mg dose. Because the FDA has already expressed concern about similar side effects in acomplia, the Merck trials looked more specifically for evidence of the effects. It seems that 28% of participants on the 2mg dose reported side effects but it is not known how severe they were.

There are two main classes of medications used to treat pain: the so-called narcotics and the non-steroidal anti-inflammatory drug. The use of the word “narcotic” has been hijacked. In its medical sense, it originally referred to drugs derived from plants that would stupefy or knock you out. In the legal sense, it refers to more or less any prohibited drug that has an addictive effect. NSAIDs painkillers are not addictive and are particularly effective to treat pain caused by inflammation.

This may not be such a good idea. The more you take, the more likely it is that you will experience one or more of the side effects. Secondly, your body builds up a tolerance for the medication so you are continually forced to increase the dose to get the same painkilling effect. This drives up the cost both physically and in cash terms. So the decisions about how much ultram to take and over what period of time are always a balancing act. You need to weigh up the benefits against the risks.

This makes the management of pain a very personal problem. Your family and friends can help keep you positive. Your financial situation may be strong. People have different levels of tolerance for pain. The management of your pain is something only you can do. Talking to doctors can give you guidance and advice but, at the end of the day, you are the one who should stay in control, making the decisions about what is best for you. If you must up the strength of the medication to one of the opiates, you will have to deal with the risk of addiction. Some of the NSAIDs also have worrying side effects over time. Make sure you take an informed decision.
To understand work of the opiates and their derivatives, think in practical terms. People who are unconscious feel no pain. So the more severe the pain, the greater the need to produce unconsciousness. For less severe pain, you need to block the pain signals and prevent them from reaching the brain. There may still be an active source of pain in the body, but the drug prevents us from becoming aware of it. If pain was the original subject, you produce a different sensation that takes your mind off it. They come to crave that level of pleasure all the time.

This should emphasize the seriousness of any decision to take pain medication. Physical and psychological dependence is a major danger if you take most of the opiates. It is a less serious problem if you take one of the atypical opioids like ultram or the NSAIDs, because they are not addictive. However, the advice of a doctor who knows your medical history is always a good idea to make sure that you will not be at risk from side effects. Some people do react adversely to medications, particularly when different medications are combined.

It is also a good idea to talk to your doctor about how to manage the pain. Ultram does not “cure” the source of the pain. Unfortunately, some illnesses and diseases cannot be cured and will cause you chronic pain, i.e. the pain will last over time. In such cases, the knee-jerk reaction is to take more ultram for longer periods of time.

Don’t risk to ask someone with chronic pain about what does it feel like. You’ll probably be discouraged by passion this person will bring down on your head. When the individuals are more sporty, they may tell you about the tennis match they were on the point of winning or the strikes they were racking up at the bowling alley. But the fairly consistent theme is that pain always follows an injury.

But, more often than not, this confuses cause and effect. Most of the time we have a condition that is slowly reducing our mobility. In everyday life, we go about our business without any awareness until there is a single twist or turn that brings the problem to our attention. This is not to deny that some people do have traffic accidents in which their necks and spine are damaged, or play sports and pick up injuries. But, most people have a moment when the minor problem becomes more obvious. It is easy to link the cause of the pain with the event and not recognize that the pain has been slowly creeping up on us for months.

No, really. Even though you might think it is obvious, pharmaceutical companies have to teach you that you solve the problem of pain by buying a medication like ultram. Wherever you look, advertisements sell the idea of science as the best treatment for pain. And there is a lot of science that backs up this idea. This is all intended to reassure the public. “Look”, it says, “you don’t have to walk around like you’re treading on eggshells. We know pain is terrible but you don’t have to be afraid anymore. Just take this pill.” Thousands of people have been through clinical trials for medications like ultram and have reported reductions in pain with few side effects.

The pharmaceutical industry needs us to keep refilling the medicine cabinet. But pain management was as much art as science. It varied from relaxation techniques to reduce tension in the muscles and to control fear (when you anticipate pain, fear magnifies the slightest twinge), to religious groups like the Christian Scientists who believed you can transcend pain through prayer.

Now let us be clear. There are some painful conditions like arthritis which so disrupt life that using ultram or an equivalent is entirely appropriate. However, the more quickly you reach for the pills, the less effect they will have over time. Tolerance reduces the effectiveness of almost every medication. So looking at alternatives to painkillers is a good idea if you know that you condition is chronic, i.e. likely to last for some time.